246 related articles for article (PubMed ID: 35612556)
41. The Rare YAP1 Subtype of SCLC Revisited in a Biobank of 39 Circulating Tumor Cell Patient Derived Explant Models: A Brief Report.
Pearsall SM; Humphrey S; Revill M; Morgan D; Frese KK; Galvin M; Kerr A; Carter M; Priest L; Blackhall F; Simpson KL; Dive C
J Thorac Oncol; 2020 Dec; 15(12):1836-1843. PubMed ID: 32721553
[TBL] [Abstract][Full Text] [Related]
42. NEUROD1 is highly expressed in extensive-disease small cell lung cancer and promotes tumor cell migration.
Ikematsu Y; Tanaka K; Toyokawa G; Ijichi K; Ando N; Yoneshima Y; Iwama E; Inoue H; Tagawa T; Nakanishi Y; Okamoto I
Lung Cancer; 2020 Aug; 146():97-104. PubMed ID: 32526603
[TBL] [Abstract][Full Text] [Related]
43. ASCL1 is a lineage oncogene providing therapeutic targets for high-grade neuroendocrine lung cancers.
Augustyn A; Borromeo M; Wang T; Fujimoto J; Shao C; Dospoy PD; Lee V; Tan C; Sullivan JP; Larsen JE; Girard L; Behrens C; Wistuba II; Xie Y; Cobb MH; Gazdar AF; Johnson JE; Minna JD
Proc Natl Acad Sci U S A; 2014 Oct; 111(41):14788-93. PubMed ID: 25267614
[TBL] [Abstract][Full Text] [Related]
44. Expression of p64c-myc and neuroendocrine properties define three subclasses of small cell lung cancer.
Bepler G; Bading H; Heimann B; Kiefer P; Havemann K; Moelling K
Oncogene; 1989 Jan; 4(1):45-50. PubMed ID: 2536917
[TBL] [Abstract][Full Text] [Related]
45. Integrative molecular analysis of combined small-cell lung carcinomas identifies major subtypes with different therapeutic opportunities.
Simbolo M; Centonze G; Ali G; Garzone G; Taormina S; Sabella G; Ciaparrone C; Mafficini A; Grillo F; Mangogna A; Volante M; Mastracci L; Fontanini G; Pilotto S; Bria E; Infante M; Capella C; Rolli L; Pastorino U; Milella M; Milione M; Scarpa A
ESMO Open; 2022 Feb; 7(1):100308. PubMed ID: 34952268
[TBL] [Abstract][Full Text] [Related]
46. Clinicopathological features and prognostic implications of ASCL1 expression in surgically resected small cell lung cancer.
Wei J; Liu L; Guo Y; Zhang J; Wang X; Dong J; Xing P; Ying J; Yang L; Li J
Thorac Cancer; 2021 Jan; 12(1):40-47. PubMed ID: 33191657
[TBL] [Abstract][Full Text] [Related]
47. Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer.
Patel AS; Yoo S; Kong R; Sato T; Sinha A; Karam S; Bao L; Fridrikh M; Emoto K; Nudelman G; Powell CA; Beasley MB; Zhu J; Watanabe H
Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33514539
[TBL] [Abstract][Full Text] [Related]
48. POU2F3: A Sensitive and Specific Diagnostic Marker for Neuroendocrine-low/negative Small Cell Lung Cancer.
Wang Y; Jin Y; Shen X; Zheng Q; Xue Q; Chen L; Lin Y; Li Y
Am J Surg Pathol; 2023 Sep; 47(9):1059-1066. PubMed ID: 37357936
[TBL] [Abstract][Full Text] [Related]
49. MUC1-C Induces the LIN28B→LET-7→HMGA2 Axis to Regulate Self-Renewal in NSCLC.
Alam M; Ahmad R; Rajabi H; Kufe D
Mol Cancer Res; 2015 Mar; 13(3):449-60. PubMed ID: 25368430
[TBL] [Abstract][Full Text] [Related]
50. In-depth proteomic analysis reveals unique subtype-specific signatures in human small-cell lung cancer.
Szeitz B; Megyesfalvi Z; Woldmar N; Valkó Z; Schwendenwein A; Bárány N; Paku S; László V; Kiss H; Bugyik E; Lang C; Szász AM; Pizzatti L; Bogos K; Hoda MA; Hoetzenecker K; Marko-Varga G; Horvatovich P; Döme B; Schelch K; Rezeli M
Clin Transl Med; 2022 Sep; 12(9):e1060. PubMed ID: 36149789
[TBL] [Abstract][Full Text] [Related]
51. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
[TBL] [Abstract][Full Text] [Related]
52. A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity.
Simpson KL; Stoney R; Frese KK; Simms N; Rowe W; Pearce SP; Humphrey S; Booth L; Morgan D; Dynowski M; Trapani F; Catozzi A; Revill M; Helps T; Galvin M; Girard L; Nonaka D; Carter L; Krebs MG; Cook N; Carter M; Priest L; Kerr A; Gazdar AF; Blackhall F; Dive C
Nat Cancer; 2020 Apr; 1(4):437-451. PubMed ID: 35121965
[TBL] [Abstract][Full Text] [Related]
53. Identification of MUC1-C as a Target for Suppressing Progression of Head and Neck Squamous Cell Carcinomas.
Nakashoji A; Haratake N; Bhattacharya A; Mao W; Xu K; Wang K; Daimon T; Ozawa H; Shigeta K; Fushimi A; Yamashita N; Morimoto Y; Shimokawa M; Saito S; Egloff AM; Uppaluri R; Long MD; Kufe D
Cancer Res Commun; 2024 May; 4(5):1268-1281. PubMed ID: 38619287
[TBL] [Abstract][Full Text] [Related]
54. [Study on the Biological Function of Abemecilib in Inhibiting the Proliferation, Invasion and
Migration of Small Cell Lung Cancer with High c-Myc Expression].
Guo J; Mu D; Yu W; Sun L; Zhang J; Ren X; Han Y
Zhongguo Fei Ai Za Zhi; 2023 Feb; 26(2):105-112. PubMed ID: 36872049
[TBL] [Abstract][Full Text] [Related]
55. Prognostic Implications of Molecular Subtypes in Primary Small Cell Lung Cancer and Their Correlation With Cancer Immunity.
Qi J; Zhang J; Liu N; Zhao L; Xu B
Front Oncol; 2022; 12():779276. PubMed ID: 35311069
[TBL] [Abstract][Full Text] [Related]
56. Molecular subtypes, predictive markers and prognosis in small-cell lung carcinoma.
Zhu Y; Li S; Wang H; Ren W; Chi K; Wu J; Mao L; Huang X; Zhuo M; Lin D
J Clin Pathol; 2023 Sep; ():. PubMed ID: 37775262
[TBL] [Abstract][Full Text] [Related]
57. POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.
Ishii J; Sato H; Sakaeda M; Shishido-Hara Y; Hiramatsu C; Kamma H; Shimoyamada H; Fujiwara M; Endo T; Aoki I; Yazawa T
Pathol Int; 2013 Mar; 63(3):158-68. PubMed ID: 23530560
[TBL] [Abstract][Full Text] [Related]
58. The KDM5A/RBP2 histone demethylase represses NOTCH signaling to sustain neuroendocrine differentiation and promote small cell lung cancer tumorigenesis.
Oser MG; Sabet AH; Gao W; Chakraborty AA; Schinzel AC; Jennings RB; Fonseca R; Bonal DM; Booker MA; Flaifel A; Novak JS; Christensen CL; Zhang H; Herbert ZT; Tolstorukov MY; Buss EJ; Wong KK; Bronson RT; Nguyen QD; Signoretti S; Kaelin WG
Genes Dev; 2019 Dec; 33(23-24):1718-1738. PubMed ID: 31727771
[TBL] [Abstract][Full Text] [Related]
59. A Comparative Study of Neuroendocrine Heterogeneity in Small Cell Lung Cancer and Neuroblastoma.
Cai L; DeBerardinis RJ; Xie Y; Minna JD; Xiao G
Mol Cancer Res; 2023 Aug; 21(8):795-807. PubMed ID: 37255415
[TBL] [Abstract][Full Text] [Related]
60. ASCL1-ERK1/2 Axis: ASCL1 restrains ERK1/2 via the dual specificity phosphatase DUSP6 to promote survival of a subset of neuroendocrine lung cancers.
Martin-Vega A; Earnest S; Augustyn A; Wichaidit C; Gazdar A; Girard L; Peyton M; Kollipara RK; Minna JD; Johnson JE; Cobb MH
bioRxiv; 2023 Jun; ():. PubMed ID: 37398419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
